Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://endpts.com/pathios-rakes-in-25m-to-help-start-trials-for-gpr65-inhibitor/
https://www.prnewswire.com/news-releases/pathios-therapeutics-raises-25m-in-first-close-of-series-b-financing-to-advance-first-in-class-immunotherapy-approach-into-clinic-302119653.html
https://www.prnewswire.com/news-releases/pathios-therapeutics-awarded-innovate-uk-grant-to-evaluate-first-in-class-immunotherapy-approach-in-models-of-malignant-brain-cancer-301939233.html
https://www.prnewswire.com/news-releases/pathios-therapeutics-to-present-preclinical-data-highlighting-potential-of-gpr65-inhibition-as-a-powerful-anti-tumor-immunotherapy-strategy-at-sitc-2022-301666778.html
https://www.prnewswire.com/news-releases/pathios-therapeutics-presents-preclinical-in-vivo-proof-of-concept-data-for-small-molecule-gpr65-inhibitor-in-human-pdx-cancer-model-301326646.html
https://www.prnewswire.com/news-releases/biohaven-announces-preliminary-2q2021-net-product-revenue-for-nurtec-odt-the-first-and-only-migraine-medication-for-both-acute-and-preventive-treatment-301326507.html
https://www.prnewswire.com/news-releases/pathios-therapeutics-presents-preclinical-in-vivo-proof-of-concept-data-for-small-molecule-gpr65-inhibitor-in-human-pdx-cancer-model-301326646.html
https://www.biospectrumasia.com/news/38/17733/pathios-therapeutics-receives-350k-funding-reward-from-innovate-uk.html